Ocular cicatricial pemphigoid, keratomycosis, and intravenous immunoglobulin therapy

Cornea

Volumn 23, Issue 8, 2004, Pages 819-822

  Iaccheri, Barbara ^a   Roque, Manolette ^a   Fiore, Tito ^a   Papadaki, Thekla ^a   Mathew, Benjamin ^b   Baltatzis, Stefanos ^a   Emara, Barry ^c   Tokarewicz, A C ^c   Foster, C Stephen ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Intravenous immunoglobulin; Keratomycosis; Keratoprosthesis; Ocular cicatricial pemphigoid

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DAPSONE; IMMUNOGLOBULIN; PREDNISONE; STEROID;

ACANTHAMOEBA; ADULT; ARTICLE; ASPERGILLUS NIGER; CASE REPORT; CONJUNCTIVAL BIOPSY; CORNEA OPACITY; CORNEA ULCER; CORNEAL BIOPSY; DISEASE COURSE; DISEASE SEVERITY; HAND MOVEMENT; HERPES VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNOMODULATION; KERATOMYCOSIS; KERATOPROSTHESIS; MALE; MUCOUS MEMBRANE PEMPHIGOID; OCULAR CICATRICIAL PEMPHIGOID; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT FAILURE; VISUAL ACUITY; XEROSIS;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS NIGER; AUTOIMMUNE DISEASES; CONJUNCTIVITIS; CORNEA; CORNEAL OPACITY; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION;

EID: 7444243805     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000127483.08466.56     Document Type: Article

References (17)

1. Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527-663.
2. Mondino BJ, Brown SI. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Am J Ophthalmol. 1983;96:453-459.
3. Brodi HJ, Pirozzi DJ. Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide. Arch Dermatol. 1977;113:1598-1599.
4. Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology. 1982;89:340-353.
5. Foster CS, Ahmed AR. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid. Ophthalmology. 1999;106:2136-2143.
6. Thomas PA. Mycotic keratitis - an underestimated mycosis. J Med Vet Mycol. 1994;32:235-256.
7. Anderson B, Roberts SS Jr, Gonzalez C, et al. Mycotic ulcerative keratitis. Arch Ophthalmol. 1959;62:169-179.
8. Kaufman HE, Wood RM. Mycotic keratitis. Am J Ophthalmol. 1965;59:993.
9. Searl SS, Udell IJ, Sadun A, et al. Aspergillus keratitis with intraocular invasion. Ophthalmol. 1981;88:1244-1250.
10. DeVoe AG. Keratomycosis. Am J Ophthalmol. 1971;71:406-414.
11. Naumann G, Green WR, Zimmerman LE. Mycotic keratitis: a histopathologic study of 73 cases. Am J Ophthalmol. 1967;64:668-682.
12. Ishibashi Y, Kaufman HE. Corneal biopsy in the diagnosis of keratomycosis. Am J Ophthalmol. 1986;101:288-293.
13. Dave VK, Vicers CFH. Azathioprine in the treatment of muco-cutaneous pemphigoid. Br J Dermatol. 1974;90:183-186.
14. Tauber J, Sainz de la Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea. 1991;10:185-195.
15. Yaghouty F, Noury M, Abad JC, et al. Preoperative prognostic categories. Cornea. 2001;20:19-23.
16. Khan B, Dudenhoefer EJ, Dohlman CH. Keratoprosthesis: an update. Curr Opin Ophthalmol. 2001;12:282-287.
17. Netland PA, Terada H, Dohlman CH. Glaucoma associated with kerato-prosthesis. Ophthalmology. 1998;105:751-757.